Skip to content
Cirpusins®
  • About Cirpusins®
    • Introduction
    • Background
    • Benefits*
    • Awards
  • Research
    • In vitro
    • Preclinical
    • Clinical
    • Pharmacokinetics
    • Publications
  • IP Rights
    • Patents
  • About Sabinsa
    • Newsroom
      • Press Releases
      • Blog Posts
      • Whitepapers
  • Contact Us

Sami-Sabinsa Group Diversifies into Information Technology and Business Solutions With Expansion of Edkal Technologies to US

Satyajit Bandyopadhyay Named CEO and Director

The Sami-Sabinsa Group, which manufactures and markets phytonutrients and standardized herbal extracts, specialty fine chemicals, and organic intermediates used in the nutritional, cosmeceutical and food industries worldwide, has expanded into the information technology and business solutions sector under the brand name Edkal Technologies.

Dr. Muhammed Majeed, Founder & Chairman, Sami-Sabinsa Group, formed Edkal Technologies in 2005 to provide IT services to the Group companies, with a few external clients. In early 2018, Edkal began its expansion into a global IT service by opening US development services and support center in addition to the Bangalore, India operation.

Edkal offers digital engineering, cloud computing, enterprise business applications, process automation and analytics in pharmaceuticals and life sciences sectors, extending into financial and manufacturing domains.

Mr. Satyajit Bandyopadhyay, a leader with proven success in strategic positioning for digital platform engineering, application R&D in IT services and manufacturing industries, involving both start-up & growth organizations, joins Edkal Technologies as the CEO and Director.

“I am honored to join Edkal Technologies, and have developed a deep appreciation for the Sami-Sabinsa Group’s culture of innovation,” said Mr. Bandyopadhyay. “I look forward to working with the entire team to achieve a leadership position in IP leveraged automation and development in the digital world.”

“The group has leveraged the most from the solutions offered by Edkal,” said Dr. Majeed. “For example, Sami Direct, the direct selling arm of the group, has benefited extremely from the digital engineering and automation solutions offered by Edkal. The process automation installed at Sami Direct has reduced the operative costs and increased both, speed and reliability of task implementation, growth, and support. We look forward to providing similar solutions to other organizations.”

He further adds “I am happy to have Satyajit Bandyopadhyay on the leadership team with his decades of experience and proven track record of spearheading revenue growth while achieving the highest level of customer satisfaction.”

About Edkal:

Founded in 2005, Edkal Technologies is a digital and automation solutions and services organization with development services and support centers in USA and India. The company has capabilities to build, deliver and support digital engineering and automation solutions and end-to-end custom software solutions; its services include digital engineering, cloud computing, enterprise business applications, process automation, and analytics.

Edkal is part of the Sami-Sabinsa Group of companies, which holds nearly 200 patents and over 600 trademarks covering a largo portfolio of alternative and complementary natural products for human nutrition sold globally.

Back

About Sabinsa

Sabinsa is a manufacturer, supplier and marketer of herbal extracts, cosmeceuticals, minerals, dietary supplements and specialty fine chemicals for the nutritional, cosmetic, pharmaceutical and food industries.

Read More...

Headquarters

Sabinsa Corporation

20 Lake Drive 

East Windsor

NJ 08520, USA

 

Tel : +1 732 777 1111

Fax: +1 732 777 1443

info@sabinsa.com

Global Contact List

USAIndia
Utah, USAJapan
AustraliaPoland
BrasilKorea
CanadaSouth Africa
ChinaVietnam
Germany 

Contact us

    © 2025 Sabinsa. All Rights Reserved | Privacy Policy | Sitemap | Terms of Use | Disclaimer

    ×

    Disclaimer

    US-FDA: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Usage disclaimer: The information pertaining to any marketing materials by Sabinsa, is for general purposes only. Users are urged to check the validity of patents if any, on any Sabinsa items for their intended use.

    EFSA: This statement has not been evaluated by the EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Australia: Please note as an ingredient supplier the information contained in this website is for marketers of finished products formulations and is not intended as consumer advice. Marketers should ensure finished products are lawful and comply with the regulations of the countries in which these items are sold. Every care has been taken to ensure the accuracy of the information provided at the time of publication.